| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |